Frontlight ResearchEarly access
Haemophilia trials in United Kingdom
6 of 17 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationAdverse Event Data Collection From External Registries on Nonacog Beta Pegol
- Where
- Sheffield
- People
- 10 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03690336 - No phaseEnrolling by invitationA Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Aberdeen, Cardiff, Manchester, Sheffield
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Birmingham, Headington, London, Newcastle upon Tyne
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - Phase 4Enrolling by invitationA Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Cambridge, Glasgow, London, Oxford, Southampton
- Age
- 18 years and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386 · EU 2023-507749-27-00 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Birmingham, Edinburgh, Glasgow, London
- People
- 4,000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119 - Phase 2/3Enrolling by invitationLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Cambridge, London, Southampton
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00